Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Eltrombopag in Pediatric Patients With Severe Aplastic Anemia
NCT03025698Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2017
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of eltrombopag in aplastic anemia, sponsored by Novartis. Started Sep 2017; status: completed.
02
Drugs
eltrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT03025698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03025698.